台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效

易威

(1799)
  • 股價
    91.8
  • 漲跌
    ▲0.9
  • 漲幅
    +0.99%
  • 成交量
    337
  • 產業
    上櫃 生技醫療類股
  • 65人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
易威 (1799)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/05/06     後一日»

券商獲利排行 - 2024/05/06

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  26.02%2,471.92.22,469.7128131372.572.573.291.8
  29.68%2,248.302,248.3107107070.870.8091.8
  26.78%775.70775.74040072.472.4091.8
  29.90%401.50401.51919070.770.7091.8
  25.75%300.80300.8161607373091.8
  27.54%297.30297.3151507272091.8
  26.80%19401941010072.472.4091.8
  25.16%166.10166.199073.373.3091.8
  25.11%165.80165.899073.473.4091.8
  24.05%106.80106.86607474091.8
  23.97%106.50106.566074.174.1091.8
  23.22%86.5086.555074.574.5091.8
  29.66%8408444070.870.8091.8
  26.26%57.3057.333072.772.7091.8
  24.05%53.4053.43307474091.8
  29.66%4204222070.870.8091.8
  29.48%41.8041.822070.970.9091.8
  26.27%38.2038.222072.772.7091.8
  26.01%37.9037.922072.872.8091.8
  25.34%37.1037.112073.273.37391.8
  24.90%36.6036.622073.573.5091.8
  24.90%36.6036.622073.573.5091.8
  24.90%36.6036.622073.573.5091.8
  23.47%34.9034.922074.474.4091.8
  30.58%21.5021.511070.370.3091.8
  29.66%2102111070.870.8091.8
  29.30%20.8020.81107171091.8
  27.62%19.9019.911071.971.9091.8
  25.75%18.8018.81107373091.8
  25.75%18.8018.81107373091.8
  25.75%18.8018.81107373091.8
  24.22%17.9017.911073.973.9091.8
  23.72%17.6017.611074.274.2091.8
  23.22%17.3017.311074.574.5091.8
  1.52%2.22.2002272.67273.191.8
  1.65%1.21.2001172.972.373.591.8
  1.40%11001171.370.871.891.8
   0000007207291.8
   00000073.3073.391.8
   00000073.1073.191.8
   0000007407491.8
   0000007407491.8
   0000007307391.8
   0000007272091.8
   0000007207291.8
   0000007307391.8
   0000007207291.8
   0000007307391.8
   0000007272091.8
   00000073.173.1091.8

券商虧損排行 - 2024/05/06

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -29.96%-2,3070-2,307-109010970.6070.691.8
  -25.16%-421-1.3-419.8-2212372.87472.791.8
  -27.18%-353.10-353.1-1801872.2072.291.8
  -29.33%-333.10-333.1-160167107191.8
  -25.45%-316.60-316.6-1701773.2073.291.8
  -19.87%-284.7-1.5-283.2-1462071.671.871.691.8
  -27.27%-275.40-275.4-1401472.1072.191.8
  -30.41%-256.90-256.9-1201270.4070.491.8
  -26.64%-212.40-212.4-1101172.5072.591.8
  -29.46%-1880-188-90970.9070.991.8
  -25.41%-1860-186-1001073.2073.291.8
  -27.50%-178.20-178.2-9097207291.8
  -26.37%-134.10-134.1-70772.6072.691.8
  -24.90%-128.10-128.1-70773.5073.591.8
  -25.93%-113.40-113.4-60672.9072.991.8
  -24.90%-109.80-109.8-60673.5073.591.8
  -27.86%-1000-100-50571.8071.891.8
  -25.10%-92.10-92.1-50573.4073.491.8
  -24.05%-890-89-5057407491.8
  -13.20%-874.2-91.2-54973.272.573.691.8
  -28.39%-81.20-81.2-40471.5071.591.8
  -27.50%-79.20-79.2-4047207291.8
  -25.24%-740-74-40473.3073.391.8
  -16.76%-72.63.9-76.5-42672.270.772.791.8
  -27.14%-58.80-58.8-30372.2072.291.8
  -26.97%-58.50-58.5-30372.3072.391.8
  -26.62%-57.90-57.9-30372.5072.591.8
  -25.75%-56.40-56.4-3037307391.8
  -25.75%-56.40-56.4-3037307391.8
  -8.56%-55.62.9-58.5-26972.171.872.391.8
  -25.18%-55.40-55.4-30373.3073.391.8
  -25.18%-55.40-55.4-30373.3073.391.8
  -24.90%-54.90-54.9-30373.5073.591.8
  -24.84%-54.80-54.8-30373.5073.591.8
  -18.59%-54.70.1-54.7-31473.573.573.691.8
  -24.05%-53.40-53.4-3037407491.8
  -26.80%-38.80-38.8-20272.4072.491.8
  -26.62%-38.60-38.6-20272.5072.591.8
  -26.36%-38.30-38.3-20272.6072.691.8
  -26.25%-38.20-38.2-20272.7072.791.8
  -9.97%-36.60.1-36.7-23573.473.473.591.8
  -24.73%-36.40-36.4-20273.6073.691.8
  -24.64%-36.30-36.3-20273.7073.791.8
  -28.03%-20.10-20.1-10171.7071.791.8
  -26.97%-19.50-19.5-10172.3072.391.8
  -26.97%-19.50-19.5-10172.3072.391.8
  -26.73%-19.40-19.4-10172.4072.491.8
  -26.45%-19.20-19.2-10172.6072.691.8
  -25.93%-18.90-18.9-10172.9072.991.8
  -25.75%-18.80-18.8-1017307391.8
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音